Comprehensive characterization of toxins during progression of inhalation anthrax in a non-human primate model.
Autorzy:
Boyer AE; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Gallegos-Candela M; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Lins RC; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Battelle Atlanta Analytical Services, Atlanta, Georgia, United States of America. Solano MI; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Woolfitt AR; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Lee JS; Biomedical Advanced Research and Development Authority, Washington, DC, United States of America. SanfordDC; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America. Knostman KAB; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America. Quinn CP; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Hoffmaster AR; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Pirkle JL; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Barr JR; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Dec 19; Vol. 18 (12), pp. e1010735. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, U.S. Gov't, Non-P.H.S.
Natural History of Marburg Virus Infection to Support Medical Countermeasure Development.
Autorzy:
Comer JE; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. Brasel T; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. Massey S; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. Cirimotich CM; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA. SanfordDC; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA. Chou YL; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA. Niemuth NA; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA. Novak J; AmplifyBio, West Jefferson, OH 43162, USA. Sabourin CL; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA. Merchlinsky M; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA. Long JP; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA. Stavale EJ; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA. Wolfe DN; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Oct 18; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 18.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
